1. Search Result
Search Result
Results for "

Mycobacteria

" in MedChemExpress (MCE) Product Catalog:

83

Inhibitors & Agonists

1

Fluorescent Dye

31

Natural
Products

2

Isotope-Labeled Compounds

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-B0329
    Isoniazid
    4 Publications Verification

    INH; Isonicotinic acid hydrazide; Isonicotinic hydrazide

    Bacterial Autophagy Mitophagy Antibiotic Infection
    Isoniazid (INH) is a proagent and must be activated by a bacterial catalase-peroxidase enzyme KatG. Isoniazid is bactericidal to rapidly dividing mycobacteria and has anti-tuberculostatic activity .
    Isoniazid
  • HY-B0901A
    Bromperidol hydrochloride
    2 Publications Verification

    R-11333 hydrochloride

    Dopamine Receptor Bacterial Neurological Disease
    Bromperidol (R-11333) hydrochloride possesses antipsychotic activity, with a high affinity for central dopamine receptors D2. Bromperidol hydrochloride can kill Mycobacteria in a synergistic manner with Spectinomycin .
    Bromperidol hydrochloride
  • HY-B0901
    Bromperidol
    2 Publications Verification

    R-11333

    Dopamine Receptor Bacterial Infection Neurological Disease
    Bromperidol (R-11333) possesses antipsychotic activity, with a high affinity for central dopamine receptors D2. Bromperidol can kill Mycobacteria in a synergistic manner with Spectinomycin .
    Bromperidol
  • HY-161135

    Bacterial Infection
    TBAJ-5307 is a broad spectrum anti-non-tuberculous mycobacteria inhibitor that can target the FO-domain of the engine and preventing rotation and proton-translocation. TBAJ-5307 inhibits non-tuberculous mycobacteria in vitro and in vivo .
    TBAJ-5307
  • HY-135285

    Antibiotic Bacterial Infection
    Rifamexil is an antibiotic Rifamycin (HY-B1907A) derivative that is active against Mycobacterium avium complex and other mycobacteria .
    Rifamexil
  • HY-B0329R

    Bacterial Autophagy Mitophagy Antibiotic Infection
    Isoniazid (Standard) is the analytical standard of Isoniazid. This product is intended for research and analytical applications. Isoniazid (INH) is a proagent and must be activated by a bacterial catalase-peroxidase enzyme KatG. Isoniazid is bactericidal to rapidly dividing mycobacteria and has anti-tuberculostatic activity .
    Isoniazid (Standard)
  • HY-N14008

    Antibiotic Bacterial Fungal Parasite Infection
    Carriomycin is an antibiotic that can be isolated from Streptomyces hygroscopicus. Carriomycin can inhibit Gram-positive bacteria, mycobacteria, yeasts and fungi, and is also an effective anticoccidial agent .
    Carriomycin
  • HY-146702

    Bacterial Thymidylate Synthase Infection
    MtTMPK-IN-8 (compound 27) is a moderate M. tuberculosis thymidylate kinase (MtbTMPK) inhibitor. MtTMPK-IN-8 has sub-micromolar activity against mycobacteria (MICs = 0.78~9.4 μM) without significant cytotoxicity. MtTMPK-IN-8 can be used for researching tuberculosis .
    MtTMPK-IN-8
  • HY-146701

    Bacterial Thymidylate Synthase Infection
    MtTMPK-IN-7 (compound 26) is a moderate M. tuberculosis thymidylate kinase (MtbTMPK) inhibitor with an IC50 value of 47 μM. MtTMPK-IN-7 has sub-micromolar activity against mycobacteria (MICs = 2.3~4.7 μM) without significant cytotoxicity. MtTMPK-IN-7 can be used for researching tuberculosis .
    MtTMPK-IN-7
  • HY-146703

    Bacterial Thymidylate Synthase Infection
    MtTMPK-IN-9 (compound 28) is a moderate M. tuberculosis thymidylate kinase (MtbTMPK) inhibitor with an IC50 value of 48 μM. MtTMPK-IN-9 has sub-micromolar activity against mycobacteria (MICs = 6.25~9.4 μM) without significant cytotoxicity. MtTMPK-IN-9 can be used for researching tuberculosis .
    MtTMPK-IN-9
  • HY-148478

    (R)-GSK1729177A

    DNA/RNA Synthesis Infection
    MMV688845 is a nontuberculous mycobacteria (NTM) RNA polymerase inhibitor with bactericidal activity against Mycobacterium abscessus and anti-tuberculosis efficacy .
    MMV688845
  • HY-A0155

    Antibiotic Bacterial Cancer
    Viomycin is a potent antibiotic against Mycobacteria. Viomycin rapidly inhibits polypeptide chain elongation when added to purified endogenous Escherichia coli polysomes actively engaged in polypeptide synthesis .
    Viomycin
  • HY-145301

    Bacterial Infection
    Mycobactin-IN-1 (compound 44), a pyrazoline analogue, is a mycobactin biosynthesis inhibitor against mycobacteria. Mycobactin-IN-1 binds to salicyl-AMP ligase (MbtA), a key enzyme in the mycobactin biosynthetic pathway .
    Mycobactin-IN-1
  • HY-118481

    Lipase Infection
    H-Pro-Glu-OH is a protein secreted by pathogenic mycobacteria through the Type VII secretion system. H-Pro-Glu-OH targets LipY lipases to the cell Surface via the ESX-5 Pathway .
    H-Pro-Glu-OH
  • HY-120733

    FKI-4905

    Bacterial Endogenous Metabolite Infection Inflammation/Immunology
    Calpinactam (FKI-4905), a fungal metabolite, is a new anti-mycobacterial agent.Calpinactam is active only against Mycobacteria among various microorganisms, including Gram-positive and Gram-negative bacteria, fungi and yeasts. Calpinactam inhibits the growth of Mycobacterium smegmatis and Mycobacterium tuberculosis with MIC values of 0.78 and 12.5 μg/ml, respectively .
    Calpinactam
  • HY-N13971

    Bacterial Infection
    Bamicetin is mainly resistant to Gram-positive bacteria and Mycobacteria .
    Bamicetin
  • HY-N14913

    Antibiotic Bacterial Infection
    Adenomycin is an antibiotic that is effective against a wide range of mycobacteria .
    Adenomycin
  • HY-N14664

    Antibiotic Bacterial Infection
    Actithiazic acid is a nitrogen- and sulfur-containing antibiotic that primarily against mycobacteria .
    Actithiazic acid
  • HY-W748035

    Antibiotic Bacterial Infection
    Etamycin A is an ester peptide antibiotic. Mainly resistant to Gram-positive bacteria and mycobacteria .
    Etamycin A
  • HY-N14902

    Antibiotic Bacterial Infection
    Mimosamycin is an antibiotic. Mimosamycin has activity against mycobacteria and streptomyces resistant strains .
    Mimosamycin
  • HY-N14727

    Antibiotic Bacterial Infection
    Primycin is a macrolide antibiotic. Primycin is active against Gram-positive bacteria, mycobacteria and protozoa .
    Primycin
  • HY-N14469

    Antibiotic Bacterial Infection
    Sakyomicin C is a Benzoquinone antibiotic. Sakyomicin C has activity against Gram-positive bacteria and mycobacteria .
    Sakyomicin C
  • HY-N14803

    Antibiotic Bacterial Fungal Infection
    Nanaomycin B is an antibiotic. Nanaomycin B has anti-Gram-positive bacteria, mycobacteria, mycoplasma and fungi activity .
    Nanaomycin B
  • HY-N13995

    Antibiotic Bacterial Fungal Infection
    Serratamolide is a depsipeptide antibiotic. Serratamolide has anti-Gram-positive bacteria, mycobacteria and fungi activity, but the activity is weak .
    Serratamolide
  • HY-118553

    Bacterial Infection
    Saframycin D has the effect of anti-Gram-positive bacteria. Saframycin D also has weak activity against mycobacteria .
    Saframycin D
  • HY-N14541

    Bacterial Infection
    Saframycin B has the effect of anti-Gram-positive bacteria. Saframycin B also has weak activity against mycobacteria .
    Saframycin B
  • HY-N14538

    Bacterial Infection
    Saframycin E has the effect of anti-Gram-positive bacteria. Saframycin B also has weak activity against mycobacteria .
    Saframycin E
  • HY-121136A

    Antibiotic Bacterial Infection
    Chartreusin sodium is an antibiotic that is active against certain Gram-positive organisms and mycobacteria. Chartreusin is also active against the Micrococcus fiyogenes v. aureus phage .
    Chartreusin sodium
  • HY-N14485

    Antibiotic Bacterial Infection
    Nebramycin IV is an aminoglycoside antibiotic. Nebramycin IV has a broad antibacterial spectrum and has a strong effect on Gram-positive and negative bacteria and mycobacteria .
    Nebramycin Ⅳ
  • HY-121136

    Antibiotic Bacterial Infection
    Chartreusin is an antibiotic that is active against certain Gram-positive organisms and mycobacteria. Chartreusin is also active against the Micrococcus fiyogenes v. aureus phage .
    Chartreusin
  • HY-N14475

    Antibiotic Bacterial Infection
    Sakyomicin B is a Benzoquinone antibiotic found in the strain of Nocardia sp. M-53. Sakyomicin B has activity against Gram-positive bacteria and mycobacteria .
    Sakyomicin B
  • HY-146699

    Bacterial Thymidylate Synthase Infection
    MtTMPK-IN-5 (compound 17) is a potent M. tuberculosis thymidylate kinase (MtbTMPK) inhibitor with an IC50 value of 34 μM. MtTMPK-IN-5 combines favorable enzyme inhibitory activity with significant activity against M. tuberculosis (MIC = 12.5 μM). MtTMPK-IN-5 can be used for researching tuberculosis .
    MtTMPK-IN-5
  • HY-W506116

    Ostruthine

    Bacterial Infection
    Ostruthin (Ostruthine) is an antimycobacterial coumarin, that can be isolated from the roots of Peucedanum ostruthium. Ostruthin causes a marked inhibition of the growth of gram-positive micro-organisms .
    Ostruthin
  • HY-146700

    Bacterial Thymidylate Synthase Infection
    MtTMPK-IN-6 (compound 1) is a potent M. tuberculosis thymidylate kinase (MtbTMPK) inhibitor with an IC50 value of 29 μM. MtTMPK-IN-6 can be used for researching tuberculosis .
    MtTMPK-IN-6
  • HY-156359

    Others Others
    Tuberculosis inhibitor 10 shows moderate inhibitory effect on the enzymatic activity of MSMEG_6649. Tuberculosis inhibitor 10 enhances the inhibitory activity of PAS against mycobacteria .
    Tuberculosis inhibitor 10
  • HY-N14677

    Bacterial Infection Cancer
    Pillaromycin A has anti-mycobacteria, Gram-positive bacteria and Gram-negative bacteria effects, but the effect of anti-Gram-negative bacteria is weak. Pillaromycin A also has antitumor activity .
    Pillaromycin A
  • HY-D1543

    DNA Stain Infection
    Pyronin B is an organic cationic dye used for the staining of bacteria, mycobacteria and ribonucleic acids. Pyronin B is also used as a small hydrophobic (SH) protein channel inhibitor .
    Pyronin B
  • HY-170519

    Bacterial Infection
    K13787 is an acetohydroxyacid synthase (AHAS) inhibitor with antibacterial activity. K13787 has antibacterial activity against a variety of nontuberculous mycobacteria (NTM) and clarithromycin (CLR) resistant strains .
    K13787
  • HY-130511

    Bacterial Infection
    FCE 22250 is a 3-azinomethylrifamycin with long-term in vivo persistence and good oral absorption. FCE 22250 shows superior efficacy against a broad antimicrobial spectrum including mycobacteria .
    FCE 22250
  • HY-145302

    Bacterial Infection
    Mycobactin-IN-2 (compound 49) is a mycobactin biosynthesis inhibitor against mycobacteria. Mycobactin-IN-2 binds to salicyl-AMP ligase (MbtA), a key enzyme in the mycobactin biosynthetic pathway .
    Mycobactin-IN-2
  • HY-10392
    Sutezolid
    4 Publications Verification

    PNU-100480; U-100480; PF-02341272

    Bacterial Antibiotic Infection
    Sutezolid (PNU-100480), an orally active oxazolidinone antimicrobial agent, acts by inhibiting bacterial protein synthesis. Sutezolid has potent activity against mycobacteria, and is used for the research of drug-resistant tuberculosis .
    Sutezolid
  • HY-162503

    Bacterial Infection
    ST166 free acid is a inhibitor of formation of the PhoP-DNA complex with the IC50 values of 18 and 24 μM against PhoP and MtrAC binding with DNA, respectively. ST166 free acid shows antibacterial activity against Macrobacterium marinum .
    ST166 free acid
  • HY-122289

    Dihydrofolate reductase (DHFR) Bacterial Infection
    Metioprim is a competitive inhibitor of bacterial Dihydrofolate reductase (DHFR). Metioprim has inhibitory activity against anaerobic bacteria. Metioprim shows synergistic activity in combination with DDS (HY-B0688) against E. coli. and various mycobacteria .
    Metioprim
  • HY-B0329S

    INH-d4; Isonicotinic acid hydrazide-d4; Isonicotinic hydrazide-d4

    Bacterial Autophagy Mitophagy Antibiotic Infection
    Isoniazid-d4 is the deuterium labeled Isoniazid. Isoniazid (INH) is a proagent and must be activated by a bacterial catalase-peroxidase enzyme KatG. Isoniazid is bactericidal to rapidly dividing mycobacteria and has anti-tuberculostatic activity[1][2][3][4].
    Isoniazid-d4
  • HY-172263

    Antibiotic Bacterial Infection
    KU13 is an inhibitor of nontuberculous mycobacteria (NTM). The minimum inhibitory concentrations (MIC) of KU13 against Mycobacterium and E. coli are 0.032-8 μg/mL and 2 μg/mL, respectively. KU13 can be used for research in the field of anti-infection .
    KU13
  • HY-119188

    Bacterial Infection Cancer
    Saframycin A has the effect of anti-Gram-positive bacteria. Saframycin A also has weak activity against Gram-negative bacteria and mycobacteria. Saframycin A has the effect of inhibiting mouse lymphocyte L-1210 with an ID50 of 0.0056 μM .
    Saframycin A
  • HY-B0901R
    Bromperidol (Standard)
    2 Publications Verification

    R-11333 (Standard)

    Dopamine Receptor Bacterial Infection Neurological Disease
    Bromperidol (Standard) is the analytical standard of Bromperidol. This product is intended for research and analytical applications. Bromperidol (R-11333) possesses antipsychotic activity, with a high affinity for central dopamine receptors D2. Bromperidol can kill Mycobacteria in a synergistic manner with Spectinomycin .
    Bromperidol (Standard)
  • HY-N14627

    Bacterial Infection
    Liposidomycin A has antibacterial effect, but the antibacterial activity is weak. Liposidomycin A has strong inhibition of mycobacteria (MIC is 0.16 μg/mL). Liposidomycin A has the function of inhibiting glycopeptide biosynthesis, and can inhibit the glycopeptide biosynthesis of E.coli with an IC50 of 0.03 μg/mL .
    Liposidomycin A
  • HY-N1969

    3,8-Di-O-methylellagic acid

    Bacterial Infection
    3,3'-Di-O-methylellagic acid obtained from Euphorbia adenochlora selectively inhibits the formation of acid-fastness in mycobacteria without retardation of their growth. 3,3'-di-O-methylellagic acid as a hepatoprotective compound is apparently due to its antioxidative effect .
    3,3'-Di-O-methylellagic acid
  • HY-162782A

    Antibiotic Bacterial Infection
    V–C6–Bg-PhCl TFA (compound 5e) is a biguanide-vancomycin conjugate. V–C6–Bg-PhCl TFA has broad-spectrum antibacterial activity against both Gram-negative and Gram-positive bacteria .
    V–C6–Bg-PhCl TFA

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: